Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.

Vertex AI is a natural language understanding ... The revamped product now also supports AMD GPUs and Nvidia NIM. Cranium AI Exposure Management Startup Cranium AI is focused on securing the ...